Closing the loop: Designing the future of sustainable drug delivery devices
Circularity requires sustainable product design and end-of-life recovery solutions.
As the pharmaceutical industry accelerates its drive towards net zero, the environmental impact of drug delivery devices is coming sharply into focus. Scope 3 emissions dominate company footprints, and end-of-life processing represents a significant proportion of a device’s CO2 emissions. This makes it essential to rethink device design and end-of-life processes. In this article, Thuysi Dao, Ypsomed's Sustainability Innovation Lead, outlines a two-pronged approach combining sustainable device design with real-world take-back and recycling initiatives, and explores how the company’s new YpsoLoop autoinjector platform embodies this vision.
With the purpose of protecting and enhancing human health, the healthcare sector plays a vital role in society. However, it also contributes substantially to the climate crisis, which is increasingly recognized as one of the greatest health threats of the modern era.
